Merck posts better-than-expected second-quarter results on Keytruda strength
By Michael Erman and Christy Santhosh Aug 4 (Reuters) – Merck reported higher-than-expected second-quarter sales on Tuesday and raised its full-year revenue forecast on the strength of its top-selling cancer…













